Safety of radium-223 dichloride (Ra-223) with docetaxel (D) in patients with bone metastases from castration-resistant prostate cancer (CRPC): A phase I Prostate Cancer Clinical Trials Consortium Study Meeting Abstract

  

Authors:	Morris, M. J.; Hammers, H. J.; Sweeney, C.; Antonarakis, E. S.; Cho, S. Y.; Pandit-Taskar, N.; Jacene, H.; Bloma, M.; Aksnes, A. K.; O'Bryan-Tear, C. G.; Carrasquillo, J. A.
Abstract Title:	Safety of radium-223 dichloride (Ra-223) with docetaxel (D) in patients with bone metastases from castration-resistant prostate cancer (CRPC): A phase I Prostate Cancer Clinical Trials Consortium Study
Meeting Title:	49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	31
Issue:	15 Suppl.
Meeting Dates:	2013 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2013-05-20
Language:	English
ACCESSION:	WOS:000335419601622
PROVIDER:	wos
DOI:	10.1200/jco.2013.31.15_suppl.5021
Notes:	Meeting Abstract: 5021 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/128741